Market Tracker

05/23 6:21am ET

Emergent BioSolutions Inc (NYSE:EBS)

29.52
Delayed Data
As of May 22
 -0.22 / -0.74%
Today’s Change
24.47
Today|||52-Week Range
41.91
-10.11%
Year-to-Date
No recent news for Emergent BioSolutions Inc.

Today’s Trading

Previous close29.74
Today’s open29.62
Day’s range29.31 - 29.91
Volume343,180
Average volume (3 months)329,541
Market cap$1.2B
Dividend yield--
Data as of 05/22/2017

Growth & Valuation

Earnings growth (last year)-19.86%
Earnings growth (this year)+1.73%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)-6.50%
P/E ratio22.5
Price/Sales3.31
Price/Book2.02

Competitors

 Today’s
change
Today’s
% change
EGRXEagle Pharmaceutical...-2.12-2.66%
INVAInnoviva Inc+0.22+1.85%
CORTCorcept Therapeutics...+0.11+0.93%
LOXOLoxo Oncology Inc+0.21+0.46%
Data as of 05/22/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)$0.17
Annual revenue (last year)$488.8M
Annual profit (last year)$51.8M
Net profit margin12.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class III Director
Daniel J. Abdun-Nabi
CFO, Treasurer &
EVP-Corporate Services
Robert G. Kramer
Corporate headquarters
Gaithersburg, Maryland

Forecasts